"10.1371_journal.pone.0035616","plos one","2012-06-06T00:00:00Z","Francesco Berlanda Scorza; Anna Maria Colucci; Luana Maggiore; Silvia Sanzone; Omar Rossi; Ilaria Ferlenghi; Isabella Pesce; Mariaelena Caboni; Nathalie Norais; Vito Di Cioccio; Allan Saul; Christiane Gerke","Novartis Vaccines Institute for Global Health, Siena, Italy; Novartis Vaccines and Diagnostics, Siena, Italy","Conceived and designed the experiments: FBS AMC SS NN VDC AS CG. Performed the experiments: FBS AMC LM SS OR IF IP MC VDC. Analyzed the data: FBS LM SS OR IF IP CG. Contributed reagents/materials/analysis tools: IF NN. Wrote the paper: FBS CG.","The authors have read the journal’s policy and have the following conflicts: Francesco Berlanda Scorza, Anna Maria Colucci, Luana Maggiore, Silvia Sanzone, Omar Rossi, Isabella Pesce, Mariaelena Caboni, Vito Di Cioccio, Allan Saul, and Christiane Gerke are or were at the time the study was conducted employees of Novartis Vaccines Institute for Global Health, Siena, Italy. Ilaria Ferlenghi and Nathalie Norais are employees of Novartis Vaccines and Diagnostics, Siena, Italy. The submitted work is included in the patent applications ‘Hyperblebbing Shigella strains’ WO/2011/036564 and ‘Purification of bacterial vesicles’ WO/2011/036562 submitted by Novartis Vaccines Institute for Global Health. This does not alter the authors’ adherence to all the PLoS ONE policies on sharing data and materials.","2012","06","Francesco Berlanda Scorza","FBS",12,TRUE,7,9,7,2,TRUE,TRUE,FALSE,0,NA,FALSE
